Thursday, 14 May 2020

MEA Anti-Fungal Agents Market By Key Vendors, Regions, Trends with Industry Study & Forecast to 2022

Market Highlights
Anti-fungal agents are used in the treatment of infections caused by fungus. According to global action fund for fungal infection, globally, over 300 million people of all ages suffer from a serious fungal infection every year. The market drivers include rising prevalence of fungal infections, rising awareness, rise of immunity deficient population such as geriatrics, rise in exposure to infectious agents due to environmental factors such as pollution especially by particulates and agriculture residues and climatic conditions such as humidity and temperature, occupational hazards such as Jock itch, crowding etc. Growth of fungal infection due to off label use of broad spectrum antibiotics is a prime factor for the growing market for anti-fungal agents.
The market restraints include rising resistance to anti-fungal agents, use of air filters and air conditioning, excellent spectrum and efficacy of Azole class of anti-fungal agents, loss of patents and genericitization etc. Competition by generics is exceptionally strong and generics account for roughly 50% of total sales for anti-fungal agents. The market penetration is very easy as there has been loss of patents of block buster drugs. Over the counter drugs are an important reasons for the growth of anti-fungal agents market.
The Middle East and Africa anti-fungal agents market is segmented into therapeutic indication which is further segmented into aspergillosis, dermatophytosis, candidiasis and others. On the basis of drug class the sub-segments are azoles, pyrimidines, echinocandins, polyenes, allylamines, and others. By route of administration the market is further divided into oral, local and others.
The market for Middle East and Africa anti-fungal agents is extremely fragmented with a number of small and big players. The market is also affected by substandard and counterfeit products especially in poorer regions of Africa with weak regulatory framework. Product development especially for resistant fungal infections has the highest potential among all the strategies.
Key Players:
The major participants of this market are: Novartis AG, Pfizer, Inc., Sanofi-Aventis, Merck & Co., Inc., Enzon Pharmaceuticals, Inc., Bayer AG, Astellas Pharma, Inc., GlaxoSmithKline plc, Abbott, Sigma-Aldrich and others
Middle East and Africa Anti-Fungal Agents Market:
The Middle East and Africa Anti-fungal agents market has been evaluated as a growing market and it is expected that the market will grow at a moderate CAGR in future. The Middle East and Africa Anti-fungal agents market is expected to grow with CAGR of ~3.5% during the forecast period. The growth will be primary channeled by the need of unmet medical needs, rising incomes of the population and the high prevalence of fungal infection in Africa. Environmental factors such as high humidity and temperature along with the rich biodiversity of Africa will positively affect the market growth of anti-fungal agents.
Regional Analysis:
Depending on geographic region, anti-fungal agents market is segmented into following countries: UAE, Egypt, Saudi Arabia, Kuwait, Qatar and Oman. UAE is the largest market followed by Egypt. However the future market will be led by the poor developed parts of Africa due to large unmet needs and the seasonal climatic conditions of Africa. The eastern parts of Africa is expected to have greater market share as compared to the hot and dry western coast.
Segmentation:
Middle East and Africa anti-fungal agents market has been segmented on the basis of therapeutic indication which comprises into aspergillosis, dermatophytosis, candidiasis and others. On the basis of drug class; market is segmented into azoles, pyrimidines, echinocandins, polyenes, allylamines, and others. On the basis of route of administration; market is segmented into oral, local and others.
Posted by at No comments:

Hepatitis C Drugs Market 2020 Global Trend, Segmentation and Opportunities - Forecast to 2022

Overview: 
Market Research Future (MRFR) has released a new report on the global hepatitis C drugs market. The report provides a complete overview of the market’s historical statistics and growth trajectory, in addition to elaborating on the market’s present statistics and providing detailed projections regarding the market’s likely growth trajectory over the forecast period from 2016 to 2022. The global hepatitis C drugs market is expected to exhibit a steady 3.3% CAGR over the forecast period, rising from a valuation of USD 18.7 billion in 2015 to USD 22.7 billion by 2022.
The slow CAGR of the global hepatitis C drugs market is due to the steady drop in the number of patients of hepatitis C in developed regions and the increasing prospects of the unorganized herbal medicine industry in emerging regions.
Thanks to consistent healthcare advancement initiatives and awareness efforts, the prevalence of hepatitis C has fallen in developed countries over the years and could in fact dip into negatives over the coming years due to the widespread availability of medication and widespread awareness about the disease. The improving sanitation levels in developed countries have been vital for the drop in the prevalence of hepatitis C, as it has reduced the likelihood of the respective pathogens breeding in large amounts. The increasing awareness about hygiene and disease prevention in countries such as the U.S., Canada, the UK, France, and Germany is likely to further reduce the prevalence of hepatitis C over the coming years, restraining the growth of the hepatitis C drugs market in developed economies.
In emerging regions such as Asia Pacific, hepatitis C is considerably prevalent. However, the disease is often treated with herbal remedies, which are available more easily and much cheaper than conventional medicine. This is likely to be a major restraint for the hepatitis C drugs market over the forecast period.
Segmentation:
The global hepatitis C drugs market is segmented on the basis of drug class, medicine system, route of administration, end user, and region.
The global hepatitis C drugs market is segmented on the basis of drug class into anti-viral drugs, immuno-modulators, and others.
On the basis of medicine system, the global hepatitis C drugs market is segmented into allopathic medicine, alternative medicine, and others.
On the basis of route of administration, the hepatitis C drugs market is segmented into oral, injectable, and others. Oral administration held the dominant share in the global hepatitis C drugs market in 2015 and is likely to remain the leading revenue generator over the forecast period.
On the basis of end user, the market is segmented into hospitals and private.

Regional Analysis:
The global hepatitis C drugs market is segmented by region into the Americas, Europe, Asia Pacific, and the Middle East and Africa.
The Americas is likely to retain the dominant share in the global hepatitis C drugs market over the forecast period, followed by Europe, due to the widespread availability of advanced medication in the region. Due to the drop in the prevalence of the disease, the hepatitis C drugs market in North America and Europe is likely to remain stable or even reduce in size over the forecast period.
The hepatitis C drugs market is likely to exhibit promising growth prospects in emerging regions such as China and India over the forecast period. The growing prevalence of the disease in these regions, allied to the growing awareness about the prevention and treatment of the disease, is likely to drive the hepatitis C drugs market over the forecast period. Growth of the healthcare sector in countries such as India, China, Japan, Korea, Indonesia, Malaysia, and Singapore is likely to be vital for the global hepatitis C drugs market over the forecast period.
Competitive Analysis:
Leading players in the global hepatitis C drugs market include Gilead Sciences Inc., Johnson & Johnson, GSK, Bristol-Myers Squibb, F. Hoffmann-La Roche Ltd., Novartis AG, Merck & Co. Inc., and AbbVie Inc.
Industry Updates:
In February 2019, Indiana’s federal court enabled Medicaid recipients to receive direct-acting antiviral medications sooner.
Posted by at No comments:

Microspheres Market By Key Vendors, Regions, Trends with Industry Study & Forecast to 2022

Global Microspheres Market – Overview
Microspheres are characteristically free flowing powders having a particle size less than 200 µm. The microspheres used are usually polymers that are classified into two material type the first one is the natural polymers and the other one is the synthetic polymers. These microspheres are used in various industries such as pharmaceutical industry, construction industry, cosmetics industry, oil & gas industry and automotive industry.
The global Microspheres market is growing with the prompt pace. The market is forecast to establish a significant growth by 2022, beyond its previous growth records in terms of value with a striking CAGR of 11.9% during the anticipated period (2017 – 2022). The global microspheres market is growing at a rapid pace. The growth of the market is majorly upsurged by various applications and advancements of microspheres in a controlled delivery system. The various application such as carriers for drugs, absorption, and desorption of substances, pulmonary drug delivery, and tissue regeneration are influencing the growth of microspheres in the field of pharmaceutical industry. Furthermore, development in new drugs, government funding in research and development of microspheres and various others applications of microspheres in the field of construction industry, cosmetics industry, oil & gas industry and automotive industry are further enhancing the market for microspheres. As there is a wide range of factors that are driving the growth of the market, there are few barriers as well that hamper the market for microspheres. One of the factors that hamper the growth of the market are fluctuating price of raw materials, huge investment in R&D and the limitation of microspheres such as, the release rate of dose may vary from one dose to another.
Global Microspheres market - Competitive Analysis
The market for microspheres is characterized by the presence of several well-established and small players, the global market for microspheres appears to be highly competitive and fragmented. Major players are increasingly expanding their footprint in the emerging nations, making it putting pressure on the regional players, especially in terms of features such as type, product portfolios, and pricing. To attract the customers the companies have launched the products of different materials and in different sizes. Some companies have adopted the strategy of acquisition and collaboration to expand their market and minimize the competition. Innovation is the best way to gain the market, thus, a number of companies are involved in the development of new and better products.
For instance, in January 2017, Telko has established a new partnership with Potters to supply performance solid and hollow microspheres for a variety of applications. This partnership can help both Potters and Sovitec to deal a more widespread, cost-effective and high-quality portfolio of products and services to the customers worldwide.
3M (Unites States), Potters Industries LLC (United States), AkzoNobel N.V. (Netherlands), Momentive Performance Materials Inc. (United States), Chase Corporation (United States), Matsumoto Yushi Seiyaku Company (Japan), Sigmund Lindner GmbH (Germany), Mo-Sci Corporation (United States), Trelleborg AB (Sweden), Luminex Corporation (United States) and others are some of the prominent players at the forefront of competition in the global Microspheres market and are profiled in MRFR Analysis. 
Global Microspheres market   - Regional Analysis
Globally, North America holds the largest share of more than 44% of global microspheres market and is expected to be the leading market during 2016-2022. This large share is majorly attributed due to growing technology advancement in the field of medical science in the region, rapidly growing pharmaceutical industry, increasing need for the new formulations for the development of new drugs, some of the key factors driving the growth of this market.
Globally Europe holds the second largest share of about 31% of the global microspheres market.  The European market is expected to reach USD 2.44 billion by the end of the forecasted period from 2016 to 2022. Asia-Pacific region is anticipated to observe the highest growth rate in the near future due to growing healthcare and life-sciences industry, increased adoption of microspheres in developing countries, are the key drivers that are influencing the market to grow at a rapid pace in this region. Furthermore, major players are grabbing the opportunity by expanding their operating sites in the region and thus increasing the growth of this market for the forecasted period from 2016 to 2022.
Posted by at No comments:

Biomarkers Market Growth Analysis, Industry Trends, and Forecast by 2027

Market Highlights
Global Biomarkers Market is expected to have a market value of USD 64,265.19 Million by 2027. Increasing applications of biomarkers, R&D funding by pharmaceutical and biotechnology companies, rising prevalence of cancer, and other chronic diseases, and new initiatives for biomarker research. Additionally, the rapidly growing population worldwide and increasing product launches by major players are likely to enhance the growth of the global biomarkers market.
Segment Analysis
Global Biomarkers Market is Segmented Based on Product, Type, Application, and Disease Indication. The biomarkers market, based on product, has been segmented into consumables, services, and software.
The biomarkers market, based on type, has been segmented into safety biomarkers, efficacy biomarkers, and validation biomarkers. The efficacy biomarkers are further segmented into predictive biomarkers, surrogate biomarkers, pharmacodynamics biomarkers, and prognostic biomarkers. The global biomarkers market, by application, has been segmented into diagnostics, drug discovery and development, personalized medicine, disease risk assessment, and others.
The global biomarkers market, by disease indication, has been segmented into cancer, cardiovascular disorders, neurological disorders, immunological disorders, and others. The segment growth can be attributed to the ability of biomarkers to cover clinical needs from cancer to infectious disease applications.
Regional Analysis
The global biomarkers market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and Middle East & Africa.
The Americas has been segmented into North America and Latin America, with the North America market further divided into the US and Canada. The Americas led the market and accounted for the largest share in 2019. The presence of prominent biopharmaceutical companies such as Merck Millipore, Bio-Rad Laboratories, Inc., Illumina, Inc., and Agilent Technologies in the US, facilitates early market initiation and prompt supply chain management. Players headquartered in other regions are also actively involved in the expansion of their facilities in the American countries to capture maximum share in the region.
The European biomarkers market has been further segmented into Western Europe and Eastern Europe. The Western Europe biomarkers market has further been classified into Germany, France, the UK, Italy, Spain, and the rest of Western Europe. Europe accounts for the second-largest share in the global biomarkers market. The rising number of conferences, seminars, and symposiums conducted by intergovernmental as well as not-for-profit organizations is increasing the level of awareness among the patients suffering from various types of cancers. For instance, European Cancer Patient Coalition (ECPC), an organization representing more than 447 organization in 46 EU and non-EU countries, in partnership with Cancer Drug Development Forum (CDDF), European Alliance for Personalized Medicine (EAPM), and International Quality Network for Pathology (IQN-Path), launched the first-ever Personalized Medicine Awareness Month in November 2018. In 2018, the Cancer Drug Development Forum (CDDF), in collaboration with ECPC, held a workshop on Biomarkers and Patients’ Access to Personalized Oncology Drugs in Europe. Such events by collaborative efforts are increasing the market size of biomarkers in Europe.
The biomarkers market in Asia-Pacific has been segmented into China, India, Japan, South Korea, Australia, and the rest of Asia-Pacific. Asia-Pacific is expected to register the highest CAGR over the forecast period from 2020 to 2027. This is owing to the growing patient population in this region. World Cancer Research Fund Data, 2018 analyzed that the age-standardized rate for all cancers for men and women together was highest in Australia, at 468.0 people per 100,000 population, which was followed by New Zealand at 438.1.
The Middle East & Africa biomarkers market is segmented into two major regions, namely the Middle East and Africa. The growth of the biomarkers market in the Middle East and Africa was considerably low in recent years. In the Middle East, the adoption rate of biomarkers was mainly in developing countries such as South Africa, the UAE, and Saudi Arabia.
Key Players
MRFR recognizes the following companies as the Key Players in the Global Biomarkers Market— Merck KGaA, Bio-Rad Laboratories, Abbott Laboratories, EKF Diagnostics, Enzo Biochem Inc., Meso Scale Diagnostics, LLC, Signosis, and PerkinElmer Inc. Qiagen N.V., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, PerkinElmer Inc.
Posted by at No comments:

2020 Worldwide Digital Pathology Market Analysis, Market Share, Application Analysis, Regional Outlook, Competitive Strategies & Forecast by 2023

Global Digital Pathology Market   - Overview
With the evolution of information technology in the past few years, a rapid change has being observed in the practice of pathology. Various novel techniques have been implemented, primarily in the form of digital imaging and Telepathology (TP). Digital pathology is a branch which can be defined as the electronic capture, management, analysis and distribution of gross or microscopic specimens. It encompasses the use of digital imaging as well as TP. Digital pathology has a wide spectrum of applications that includes primary diagnosis, intraoperative diagnosis, consultation, quality assurance, archiving, research and academic studies. This technique helps in speeding up the process of diagnosis and further treatment. It also helps in research procedures by offering an easy access to the previously stored digital information. As per the Royal College of Pathologists, in the UK alone pathologists carry out 121,000 autopsies each year which has supported the market growth.
The global digital pathology market is growing with the rapid pace; mainly due technologically advanced diagnostic tools for the chronic diseases such as cancer has upsurged the demand for digital pathology. According to a recent study report published by the Market Research Future, The global digital pathology market is booming and expected to gain prominence over the forecast period growing rapidly. The market is forecasted to demonstrate a spectacular growth by 2022, surpassing its previous growth records in terms of value with a striking CAGR during the anticipated period (2017 – 2022).
The market is expected grow with the same trends during the forecast period. The major drivers will be rapid technological advancements in digital pathology system such as advancements in digital imaging, robotic light microscopy, and multiple fiber optic communications among others. Moreover, growing prevalence of chronic conditions, that has expected to uplift the demand for digital pathology in order to improve existing patient diagnostic imaging measures and reduce high cost associated with the traditional diagnostics methods. For instance, as per National Pathology Programme, nearly 800 million tests are being performed annually which is equal to 14 for each person in England and Wales. Additionally, increasing R&D applications of static and dynamic systems is fostering the market growth of digital pathology market.
Global Digital Pathology Market   - Competitive Analysis
The market for digital pathology is characterised by the presence of several well-established and small players, the global market of digital pathology appears to be highly competitive and fragmented. Global players are increasingly expanding their footprint in the emerging nations, making it putting pressure on the regional players, especially in terms of features such as type, product portfolios, and pricing. The market is witnessing intensified competition which is expected to get more intensified further during the forecast period. Well established players are entering into mergers & acquisitions, collaboration, partnership, expansion, and product launch in order to gain competitive advantage in this market and to maintain their market position.  
Companies like Leica Biosystems; Hamamatsu Photonics, Inc.; and Olympus Corporation are increasingly adopting extensive collaborative strategies to gain more profits and capturing new markets. For instance, in March 2017, Leica Biosystems entered into a strategic partnership with Leeds Hospital to improve productivity and workflow.
Key participants like Royal Philips has acquired the Irish PathXL, one of the largest pathology, image-based analysis firms in order to develop integrated tools targeting applications in computational biology, workflow solutions, education, and image analytics. In addition, these key activities the companies are aiming towards supporting the gradual transition of medical institutions present across the globe from the conventional pathology systems to digital pathology systems.
Thus, we can say that these competitive developments will further enable pathologists to perform high-throughput analysis of clinical image datasets that are diverse in nature and expedite improvement in the diagnosis quality, thereby presenting a potential for adoption new ad improved therapies to enhance patient health outcomes.
microDimensions GmbH (Germany), Mikroscan Technologies, Inc. (U.S.), Q2 Solutions (U.S.), Omnyx, LLC (U.S.), GE Healthcare (UK), Philips Healthcare (U.S.), Huron Digital Pathology Inc. (Canada), ViewsIQ Inc. (Canada), 3DHISTECH Ltd (Hungary) Apollo Enterprise Imaging Corp. (U.S.), Xifin Inc. (U.S.), Definiens (Germany) and others. are some of the prominent players at the forefront of competition in the Global Digital Pathology Market and are profiled in MRFR Analysis. 
Posted by at No comments:

Apheresis Market 2020: Size, Upcoming Trends, On-Going Demand, Growth and Forecast from 2020 to 2023 with Most Prominent Key Players

Market Scenario
The global apheresis market is presumed to register 10.2 % CAGR during the forecast period (2017-2023), owing to the increasing prevalence of chronic renal diseases, asserts Market Research Future (MRFR). Apheresis is referred to as the procedure of separating and purifying the blood for treating several renal, neurological, autoimmune, hematological, and other diseases. Apheresis involves removal of the blood from the donor or patients and collecting it into an apparatus which separates the component from the blood. The rest of the blood is sent to the patients or the donors. The separation is mainly done using filtration and centrifugation.
Drivers and Constraints Impacting the Market
With the growing prevalence of chronic renal diseases and blood-related diseases, the global apheresis market is considered to stimulate during the estimated period. Increasing complex surgical procedures, rising demand for different component of blood, and growing number of accidents across the globe are considered to augment the market growth in the coming years. Demand for platelets and plasma has also increased which is further impacting the global market positively. Moreover, with continuous advancement in technology and growing need for advanced and automated devices, the market is likely to foster.
On the flip side, high cost of procedures and lack of skilled professionals are some of the major factors considered to impede the market growth in the coming years.
Global Apheresis Market: Segmental Analysis
The global apheresis market has been segmented on the basis of product, procedure, methods, application, end-users, and region.
By mode of product, global apheresis market has been segmented into devices and disposables. The devices segment has been further sub-segmented into platelets separators, plasma separators, and others.
By mode of procedure, the global apheresis market has been segmented into leukapheresis, plateletpheresis, plasmapheresis, erythrocytapheresis, and others.
By mode of methods, the global apheresis market has been segmented into filtration and centrifugation. Among these, centrifugation is further sub-segmented into intermittent flow centrifugation, continuous flow centrifugation, and others.
By mode of application, the global apheresis market has been segmented into oncological diseases, immunological diseases, hematological diseases, cardiovascular diseases, renal diseases, neurological diseases, and others.
By mode of end-users, the global apheresis market has been segmented into hospitals, blood banks, and others.
Regional Insights
Geographically, apheresis market span across regions namely, America, Europe, Asia Pacific, and Rest-of-the-World (RoW).
Among all the regions, America is considered to hold the largest position in the global market and is expected to maintain its dominance during the assessment period. The growth is attributed to the advancement in technology and growing opportunity for apheresis products coupled with the presence of a huge patient population suffering from chronic diseases.
Asia Pacific is considered to be the fastest growing region in the global market owing to the growing demand for blood components for patients. Moreover, rapid development in the healthcare industry along with growing expenditure on health care is considered to contribute to the growth of the global market.
Industry Updates
January 2018: MedAware Systems Inc. has recently launched a comprehensive database on apheresis through its SOHInfo division, carrying data from clinical trials, medical journals, cohort studies, and others.
Competitive Dashboard
The major players operating the global market are Kaneka Corporation (Japan), Terumo BCT Inc. (US), Fresenius Medical Care (Germany), Nikkiso Co. Ltd. (Japan), Asahi Kasei Medical Co. Ltd. (Japan), B. Braun Melsungen AG (Germany), Nikkiso Ltd. (Japan), HemaCare Corporation (US), Cerus Corporation (US), Haemonetics Corporation (US), Kawasumi Laboratories Inc. (Japan), Therakos, Inc. (U.S.), and others.
Posted by at No comments:

Menstrual Cup Market Overview with Detailed Analysis, Competitive landscape, Forecast to 2023

Market Scenario
The menstrual cup market is predicted to expand at 3.50 % CAGR over the assessment period (2018-2023 due to the growth in women population, asserts Market Research Future (MRFR). An eco-friendly alternative to tampons and sanitary pads, menstrual cup is derived from medical-grade silicone. It is a female sanitary product that comes in the form of a bell-shaped cup and can be inserted into the vagina during menstruation. Such cups prevent leakage of menstrual fluids which makes it highly convenient.
Drivers and Restraints Impacting the Market
Menstrual cup possess a lifespan ranging from 1-10 years and is one of the most affordable solutions for female hygiene. They are reusable, thus making their demand high. With the growing awareness regarding menstrual cups among the female population, availability of a variety of cups with different sizes, and increasing campaigns conducted by the educational institutes, manufacturers, and the women community are considered some of the major factors propelling the market growth. Government is taking initiatives to educate women about hygiene. Also, the guidelines to use the cup is triggering the product demand in the global market. For example, in 2015, South Africa launched Serithi Campaign which aimed to address the issues faced by young girls the during menstrual cycle.
On the flip side, conservative societies have a low-level acceptance of such products which is expected to retard the market growth in the coming years. Also, tough competition faced from other menstrual product manufacturers can inhibit the market growth.
Global Menstrual Cup Market Segmentation
The market is segmented on the basis of type, product, and distribution channel.
By mode of product, the market is segmented into disposable menstrual cup and reusable menstrual cup. Reusable menstrual cup is presumed to dominate the market during the forecast period. The growth can be attributed to the reusability cycle of these cups which ranges from 1 to 5 years. Moreover, these products are cost-effective and eco-friendly which makes them highly demanding.
By mode of type, the market is segmented into pointy, hollow, flat, and round. Among these, the round menstrual cups account for 43 % of the market share due to the flexible design of such products.
By mode of distribution channel, the market is segmented into retail outlets, online stores, and others. Among these, online store channels account for 62 % of the market share due to penetration of e-commerce stores.
Regional Insights
America is presumed to lead the global menstrual cup market during the assessment period. Programs conducted by the government to create awareness among the consumers is likely to propel the market growth. Also, with the presence of major manufacturers such as LENA Cup and Diva International are likely to propel the market growth.
European is predicted to lead the global market owing to the presence of established players. Also, with the increasing health care cost, the demand for menstrual cup is estimated to trigger in this region.
Asia Pacific is presumed to be the third largest market and registers a steady growth in the healthcare sector. The major contributors are Japan, India, China, the Republic of Korea, and Australia. The market is likely to expand owing to the several awareness programs conducted by the organizations and the government in this region.
Industry News
Loon Labs has created reusable cups which tracks the color and volume of the menstrual fluid. It is the world’s first Bluetooth connected menstrual cup which offers women with analytics and tools to monitor their bodies by using metrics.
Competitive Analysis
As the market continues to propel, it is becoming highly fragmented with the presence of local vendors and established players. The major players operating the global market are Diva International Inc., Vcup, Anigan, Ruby Life Ltd., LadyCup, FemCap Inc., Me Luna, The Keeper Inc., Irisana S.A., and Lunette  
Posted by at No comments:
Subscribe to: Posts (Atom)